Inventor
SCHRIMPF MICHAEL R
US36 patents
⚠️ This page may combine multiple inventors who share the name “SCHRIMPF MICHAEL R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBOTT LAB
12 patentsUS6809105B2Oct 26, 2004
Diazabicyclic central nervous system active agents
ABBOTT LAB53 citations95
US7399765B2Jul 15, 2008
Substituted diazabicycloalkane derivatives
ABBOTT LAB33 citations92
US6833370B1Dec 21, 2004
Heterocycle substituted aminoazacycles useful as central nervous system agents
ABBOTT LAB40 citations91
US7319106B2Jan 15, 2008
Diazabicyclic central nervous system active agents
ABBOTT LAB5 citations73
US7897766B2Mar 1, 2011
Amino-aza-adamantane derivatives and methods of use
ABBOTT LAB3 citations62
US7365193B2Apr 29, 2008
Amino-substituted tricyclic derivatives and methods of use
ABBOTT LAB3 citations62
US7994223B2Aug 9, 2011
Amide derivatives as positive allosteric modulators and methods of use thereof
ABBOTT LAB3 citations61
US7786171B2Aug 31, 2010
Amide derivatives as positive allosteric modulators and methods of use thereof
ABBOTT LAB3 citations61
US7332504B2Feb 19, 2008
Heterocyclic substituted aminoazacycles useful as central nervous system agents
ABBOTT LAB2 citations61
US7598236B2Oct 6, 2009
Diazabicyclic central nervous system active agents
ABBOTT LAB0 citations52
US7951791B2May 31, 2011
Amino-substituted tricyclic derivatives and methods of use
ABBOTT LAB0 citations51
US7265115B2Sep 4, 2007
Diazabicyclic CNS active agents
ABBOTT LAB1 citations49
SCHRIMPF MICHAEL R
8 patentsUS8314119B2Nov 20, 2012
Azaadamantane derivatives and methods of use
SCHRIMPF MICHAEL R22 citations92
US8846661B2Sep 30, 2014
Diazahomoadamantane derivatives and methods of use thereof
SCHRIMPF MICHAEL R17 citations83
US8586746B2Nov 19, 2013
Amino-aza-adamantane derivatives and methods of use
SCHRIMPF MICHAEL R3 citations62
US8163916B2Apr 24, 2012
Azaadamantane ester and carbamate derivatives and methods of use thereof
SCHRIMPF MICHAEL R5 citations62
US8119635B2Feb 21, 2012
Diazabicyclic central nervous system active agents
SCHRIMPF MICHAEL R2 citations62
US9063126B2Jun 23, 2015
Indole and indoline derivatives and methods of use thereof
SCHRIMPF MICHAEL R2 citations61
US9625475B2Apr 18, 2017
Indole and indoline derivatives and methods of use thereof
SCHRIMPF MICHAEL R1 citations51
US8268853B2Sep 18, 2012
3,9-diazaspiro[5,5]undecane amides and ureas and methods of use thereof
SCHRIMPF MICHAEL R0 citations51
ABBVIE INC
7 patentsUS8987453B2Mar 24, 2015
Azaadamantane derivatives and methods of use
ABBVIE INC6 citations83
US8648074B2Feb 11, 2014
Substituted octahydropyrrolo[1,2-a]pyrazine sulfonamides as calcium channel blockers
ABBVIE INC6 citations72
US10508113B2Dec 17, 2019
Inhibitors of tyrosine kinase 2 mediated signaling
ABBVIE INC3 citations66
US9382258B2Jul 5, 2016
Agents for treating pain and uses thereof
ABBVIE INC0 citations50
US9029361B2May 12, 2015
Agents for treating pain and uses thereof
ABBVIE INC0 citations50
US9983218B2May 29, 2018
Indole and indoline derivatives and methods of use thereof
ABBVIE INC0 citations46
US8669255B2Mar 11, 2014
Substituted octahydropyrrolo[1,2-a]pyrazines as calcium channel blockers
ABBVIE INC0 citations41